BENESSERE CAPITAL ACQUI-CL A (BENE) Fundamental Analysis & Valuation

NASDAQ:BENE • US08179B1035

10.44 USD
0 (0%)
Last: Oct 31, 2022, 08:06 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This BENE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

1

Taking everything into account, BENE scores 1 out of 10 in our fundamental rating. BENE was compared to 0 industry peers in the Unkown industry. BENE scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. BENE has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

0

1. BENE Profitability Analysis

1.1 Basic Checks

  • In the past year BENE has reported negative net income.
  • BENE had a negative operating cash flow in the past year.
BENE Yearly Net Income VS EBIT VS OCF VS FCFBENE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 0 1M -1M 2M

1.2 Ratios

Industry RankSector Rank
ROA -0.11%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BENE Yearly ROA, ROE, ROICBENE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 0 100 200 300

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for BENE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BENE Yearly Profit, Operating, Gross MarginsBENE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. BENE Health Analysis

2.1 Basic Checks

  • Compared to 1 year ago, BENE has more shares outstanding
  • There is no outstanding debt for BENE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
BENE Yearly Shares OutstandingBENE Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 5M 10M
BENE Yearly Total Debt VS Total AssetsBENE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 20M 40M 60M 80M 100M

2.2 Solvency

  • BENE has an Altman-Z score of 7.99. This indicates that BENE is financially healthy and has little risk of bankruptcy at the moment.
  • There is no outstanding debt for BENE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 7.99
ROIC/WACCN/A
WACCN/A
BENE Yearly LT Debt VS Equity VS FCFBENE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 0 20M 40M 60M 80M 100M

2.3 Liquidity

  • A Current Ratio of 0.00 indicates that BENE may have some problems paying its short term obligations.
  • A Quick Ratio of 0.00 indicates that BENE may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0
Quick Ratio 0
BENE Yearly Current Assets VS Current LiabilitesBENE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 200K 400K 600K 800K

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. BENE Growth Analysis

3.1 Past

  • BENE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 4461.58%, which is quite impressive.
EPS 1Y (TTM)4461.58%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%254.47%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocksShow best growing peers

0

4. BENE Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for BENE. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BENE Price Earnings VS Forward Price EarningsBENE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BENE Per share dataBENE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. BENE Dividend Analysis

5.1 Amount

  • No dividends for BENE!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

BENE Fundamentals: All Metrics, Ratios and Statistics

BENESSERE CAPITAL ACQUI-CL A

NASDAQ:BENE (10/31/2022, 8:06:38 PM)

10.44

0 (0%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners3.56%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap143.27M
Revenue(TTM)N/A
Net Income(TTM)-114.40K
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.48
P/tB 1.48
EV/EBITDA N/A
EPS(TTM)-0.01
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.06
FCFYN/A
OCF(TTM)-0.06
OCFYN/A
SpS0
BVpS7.05
TBVpS7.05
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -0.11%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0
Quick Ratio 0
Altman-Z 7.99
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)4461.58%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%254.47%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-4888.45%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-4888.45%
OCF growth 3YN/A
OCF growth 5YN/A

BENESSERE CAPITAL ACQUI-CL A / BENE FAQ

Can you provide the ChartMill fundamental rating for BENESSERE CAPITAL ACQUI-CL A?

ChartMill assigns a fundamental rating of 1 / 10 to BENE.


What is the valuation status of BENESSERE CAPITAL ACQUI-CL A (BENE) stock?

ChartMill assigns a valuation rating of 1 / 10 to BENESSERE CAPITAL ACQUI-CL A (BENE). This can be considered as Overvalued.


What is the profitability of BENE stock?

BENESSERE CAPITAL ACQUI-CL A (BENE) has a profitability rating of 1 / 10.


How financially healthy is BENESSERE CAPITAL ACQUI-CL A?

The financial health rating of BENESSERE CAPITAL ACQUI-CL A (BENE) is 2 / 10.